YD Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	161	863	-	-	-
Market Cap Growth	292.84%	-	-	-	-
Enterprise Value	158.27	856.92	0	0	0
Last Close Price	2.30	12.19	-	-	-
PS Ratio	316.22	1445.87	-	-	-
PB Ratio	0.50	-302.18	-	-	-
EV/Sales Ratio	310.12	1435.82	-	-	-
Debt / Equity Ratio	-	0	0.00	0	-
Net Debt / Equity Ratio	2.10	2.10	-0.47	-1.72	-
Net Debt / EBITDA Ratio	1.19	1.19	2.29	5.34	-
Net Debt / FCF Ratio	0.75	0.75	2.40	0.71	-
Asset Turnover	0.06	0.06	0.14	2.18	-
Inventory Turnover	0.45	0.45	6.65	5.67	-
Quick Ratio	3.93	3.93	12.30	0.62	-
Current Ratio	5.88	5.88	13.18	0.91	-
Return on Equity (ROE)	-445.10%	-445.10%	-42.69%	117.94%	-
Return on Assets (ROA)	-51.06%	-51.06%	-41.43%	-4.71%	-
Return on Invested Capital (ROIC)	-43.43%	-67.50%	-85.94%	-	-
Return on Capital Employed (ROCE)	-56.27%	-56.27%	-44.14%	-85.65%	-
Buyback Yield / Dilution	-4.01%	-5997.83%	98.31%	-6053.10%	-
Total Shareholder Return	-4.01%	-5997.83%	98.31%	-6053.10%	-

SEC Filings: 10-K · 10-Q